TAK-652, a novel CCR5 inhibitor, has favourable drug interactions with other antiretrovirals in vitro.

Tremblay, Cécile L

TAK-652, a novel CCR5 inhibitor, has favourable drug interactions with other antiretrovirals in vitro. [electronic resource] - Antiviral therapy 2005 - 967-8 p. digital

Publication Type: Letter

1359-6535


Anti-Retroviral Agents--pharmacology
CCR5 Receptor Antagonists
Cells, Cultured
Drug Synergism
HIV-1--drug effects
Imidazoles--pharmacology
Sulfoxides